ZA928727B - 3-sulfonylamino-2(1H)-quinolone compounds, process for preparing them and pharmaceutical compositions containing them. - Google Patents
3-sulfonylamino-2(1H)-quinolone compounds, process for preparing them and pharmaceutical compositions containing them.Info
- Publication number
- ZA928727B ZA928727B ZA928727A ZA928727A ZA928727B ZA 928727 B ZA928727 B ZA 928727B ZA 928727 A ZA928727 A ZA 928727A ZA 928727 A ZA928727 A ZA 928727A ZA 928727 B ZA928727 B ZA 928727B
- Authority
- ZA
- South Africa
- Prior art keywords
- branched
- linear
- trihalomethyl
- unsubstituted
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9113977A FR2683818B1 (fr) | 1991-11-14 | 1991-11-14 | Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA928727B true ZA928727B (en) | 1993-05-10 |
Family
ID=9418879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA928727A ZA928727B (en) | 1991-11-14 | 1992-11-12 | 3-sulfonylamino-2(1H)-quinolone compounds, process for preparing them and pharmaceutical compositions containing them. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0542609B1 (xx) |
JP (1) | JPH06102650B2 (xx) |
AT (1) | ATE111082T1 (xx) |
AU (1) | AU651255B2 (xx) |
CA (1) | CA2082856A1 (xx) |
DE (1) | DE69200394T2 (xx) |
DK (1) | DK0542609T3 (xx) |
ES (1) | ES2064156T3 (xx) |
FR (1) | FR2683818B1 (xx) |
NZ (1) | NZ245127A (xx) |
ZA (1) | ZA928727B (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2709489B1 (fr) * | 1993-08-31 | 1995-10-20 | Adir | Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
FR2750988B1 (fr) * | 1996-07-11 | 1998-09-18 | Adir | Nouveaux derives de 2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US20020065296A1 (en) | 1999-01-13 | 2002-05-30 | Bayer Corporation | Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
EP1690853B1 (en) | 1999-01-13 | 2010-03-10 | Bayer HealthCare LLC | Use of omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
EP1158985B1 (en) | 1999-01-13 | 2011-12-28 | Bayer HealthCare LLC | OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
EP1212330B1 (en) | 1999-08-27 | 2006-04-19 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
US6566372B1 (en) | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
EP1212322A2 (en) | 1999-08-27 | 2002-06-12 | Ligand Pharmaceuticals Incorporated | 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
EP1216221A2 (en) | 1999-09-14 | 2002-06-26 | Ligand Pharmaceuticals Incorporated | Rxr modulators with improved pharmacologic profile |
FR2805262A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides aryle ou heteroaryle quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2805260A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides 6-sulfamoyl-3-quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2805261A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
TWI298068B (en) * | 2000-06-21 | 2008-06-21 | Dainippon Sumitomo Pharma Co | Pharmaceutical composition for schizophrenia |
PL1636585T3 (pl) | 2003-05-20 | 2008-10-31 | Bayer Healthcare Llc | Diarylowe pochodne mocznika inhibowane kinazą |
CA2536349A1 (en) | 2003-08-22 | 2005-03-03 | Ligand Pharmaceuticals Incorporated | 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds |
WO2007053574A2 (en) | 2005-10-31 | 2007-05-10 | Bayer Pharmaceuticals Corporation | Combinations comprising sorafenib and interferon for the treatment of cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3066145A (en) * | 1962-02-07 | 1962-11-27 | American Home Prod | 3-amino-6-chloro-4-phenyl-2(1h)-quinolone |
IL93610A0 (en) * | 1989-03-08 | 1990-12-23 | Merck Sharp & Dohme | Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them |
GB9004288D0 (en) * | 1990-02-26 | 1990-04-18 | Almirall Lab | New 4(1h)quinoline derivatives |
-
1991
- 1991-11-14 FR FR9113977A patent/FR2683818B1/fr not_active Expired - Fee Related
-
1992
- 1992-11-09 DE DE69200394T patent/DE69200394T2/de not_active Expired - Fee Related
- 1992-11-09 DK DK92403014.1T patent/DK0542609T3/da active
- 1992-11-09 EP EP92403014A patent/EP0542609B1/fr not_active Expired - Lifetime
- 1992-11-09 AT AT92403014T patent/ATE111082T1/de active
- 1992-11-09 ES ES92403014T patent/ES2064156T3/es not_active Expired - Lifetime
- 1992-11-12 ZA ZA928727A patent/ZA928727B/xx unknown
- 1992-11-13 CA CA002082856A patent/CA2082856A1/fr not_active Abandoned
- 1992-11-13 NZ NZ24512792A patent/NZ245127A/en unknown
- 1992-11-13 AU AU28351/92A patent/AU651255B2/en not_active Ceased
- 1992-11-16 JP JP4305550A patent/JPH06102650B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK0542609T3 (da) | 1995-03-20 |
AU2835192A (en) | 1993-05-20 |
ES2064156T3 (es) | 1995-01-16 |
DE69200394T2 (de) | 1995-04-27 |
FR2683818A1 (fr) | 1993-05-21 |
JPH06102650B2 (ja) | 1994-12-14 |
FR2683818B1 (fr) | 1993-12-31 |
EP0542609B1 (fr) | 1994-09-07 |
CA2082856A1 (fr) | 1993-05-15 |
AU651255B2 (en) | 1994-07-14 |
DE69200394D1 (de) | 1994-10-13 |
EP0542609A1 (fr) | 1993-05-19 |
JPH05221997A (ja) | 1993-08-31 |
ATE111082T1 (de) | 1994-09-15 |
NZ245127A (en) | 1994-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA928727B (en) | 3-sulfonylamino-2(1H)-quinolone compounds, process for preparing them and pharmaceutical compositions containing them. | |
TW385309B (en) | Novel thiazolidinedione antidiabetic agents | |
DE10199003I2 (xx) | ||
GB8919434D0 (en) | Novel compounds | |
MY101541A (en) | Indolizine derivatives, process for preparing them and the compositions containing them | |
GB8919417D0 (en) | Novel compounds | |
HUT66018A (en) | Process for the preparation of baccatin iii and 10-deacetyl baccatin iii derivatives | |
ZA946659B (en) | 2(1h)-quinolone compounds process for preparing them and pharmaceutical compositions containing them | |
DK508484A (da) | N-substituerede isoquinolinderivater og farmaceutisk praeparat indeholdende dem | |
IE790556L (en) | Benzylidene derivatives | |
IL106564A (en) | Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them | |
EP0424248A3 (en) | 20,21-dinoreburnamine derivatives, substituted in position 15, process for their preparation and novel intermediates so obtained, their use as medicines and compositions containing them | |
ES488388A1 (es) | Procedimiento de preparacion de derivados hidroxilados del tiazol | |
SE9002445D0 (sv) | Nytt cyklobutanderivat och foerfarande foer framstaellning av detsamma |